SiBionics

SiBionics is a Shenzhen-based medical technology company founded in 2015 that develops biosensing devices for chronic disease management, with more than 40 percent of its staff in research and development. Its flagship GS series continuous glucose monitoring sensors provide 14 days of calibration-free, real-time glucose readings without fingersticks, with data delivered every 5 minutes to a smartphone app and shareable with clinicians through the ProView remote monitoring platform.

The GS1 CGM received its CE Mark in 2023, opening European distribution, and the newer GS3 adds an ultra-slim profile and water resistance. Beyond glucose, the company builds hospital-wide digital blood glucose management solutions, the SiBio KS series of continuous ketone monitoring wearables and AI-assisted retinal screening software, and reports 4 million users in more than 100 countries.

We distribute SiBionics CGM in Mauritius as part of our consumer-facing Medshop range, and our group operates a dedicated local brand site at sibionics.mu with product information and ordering for patients and clinicians.